Blood and Marrow Transplantation
The Blood and Marrow Transplant (BMT) Program has achieved national renown since opening in 1990.
The complex transplantation procedure uses stem cells isolated in bone marrow or blood, either from a compatible donor (related or unrelated) or the patient’s own bone marrow or blood. In addition to the use of transplantation for the treatment of acute and chronic leukemias, we are utilizing transplantation as an important means of treating non-Hodgkin’s lymphoma, Hodgkin’s disease, multiple myeloma, and other forms of cancer.
In addition, our program is the second largest collection center in the United States for the National Marrow Donor Program.
Members of the Transplant Program have been active participants in clinical trials sponsored by the National Heart, Lung and Blood Institute, as well as clinical trials through the Cancer and Leukemia Group B (CALGB), a national cooperative group for clinical trials research supported by the National Cancer Institute.